Conclusion: EuroSCORE II was validated and performed well on National Heart Foundation patients and could be recommended as a simple risk stratification system to estimate the probability of early mortality in patients scheduled for valve surgery in Bangladesh.
Introduction
Preoperative risk stratification has become a core issue for patients with valve surgery, because progress in operative and perioperative care has led to a wide extension of surgical indications, addressing by surgical intervention even patients with severe multiple comorbidities who were previously treated with medical therapy. In this scenario, perioperative death cannot be considered the only quality measure, and the overall preoperative assessment of patients should also take into account the life expectancy after the valve operation (Fabio, et al., 2016) .
EuroSCORE (European System for Cardiac Operative Risk Evaluation) is a risk model which allows the calculation of the risk of death after a heart operation. EuroSCORE, first developed as an additive model (additive EuroSCORE, AES) first published in 1999. It was based on data collected from 128 centers of eight European countries (German, France, United Kingdom, Italy, Spain, Finland, Sweden and Switzerland). The model asks for 17 items of information about the patient, the state of the heart and the proposed operation, and uses logistic regression to calculate the risk of death. However this model generally overestimates mortality in low risk patients and underestimates it in high risk groups (Shanmugam,et al., 2005) .
Then logistic EuroSCORE (LES) was published in 2003 (Roques, et al., 2003) to gain predictive performance in high risk group. The model has been adopted worldwide, becoming the most widely used risk index for cardiac surgery. Over the last few years, several professionals from many parts of the world have reported that the model now overpredicts risk, as a result of cardiac surgery have improved significantly. To overcome this effect an updated version of this model named EuroSCORE II -was announced at the EACTS meeting in Lisbon on Monday, 3 October 2011 and published in the European Journal of Cardiothoracic Surgery in April 2012, based on the logistic regression analysis of 23,000 patients in 150 hospitals in 43 countries over a 12 week period (MayJuly 2010) (Mohammad, et al., 2016) .
Euroscore II, the updated version, has better discriminative power & calibration. The discriminative power is important to determine how the model distinguishes between alive & died patients during in-hospital period .Calibration is also important to determine the agreement between the real observed & predicted mortality. The discriminatory power and precision in risk prediction of the EuroSCORE -II in mitral and aortic valve surgery has recently become increasingly important for 2 reason .First -In the most centers, valve procedures, either isolated or combined actually represent more than 30% of the total caseload, therefore, accurate risk estimation in this patient population, mainly elderly and very elderly people has become much more important. The second reason, is strictly related to the recent evolution in technical options in valve operations-minimally invasive valve surgery in patients at the high risk.
In UK, a dedicated website collected prospective risk and outcome data on 22,381 consecutive patients undergoing major cardiac surgery in 154 hospitals in 43 countries over a 12-week period (May-July 2010). Information was obtained on existing EuroSCORE risk factors and additional factors proven to influence risk from research conducted since the original model. The outcome was early mortality after valve surgery (within 30 days). A logistic risk model (EuroSCORE II) was then constructed and tested. Results shows Compared with the original 1995 EuroSCORE database (in brackets) Overall mortality was 3.9% (4.6%). When applied to the current data, the old risk models over predicted mortality (actual: 3.9%; additive predicted: 5.8%; logistic predicted: 7 .57%). EuroSCORE II was well calibrated on testing in the validation data subset of 5553 patients (actual mortality: 4.18%; predicted: 3.95%). Very good discrimination was maintained with an area under the receiver operating characteristic curve of 0.8095 (Nashef, et al., 2012) .
A literature search identified 37 potentially eligible studies, and 12 were selected for meta-analysis comprising 26,621 patients with 1250 events (mortality rate, 4.7%). Meta-analysis of these studies provided an average area under the curve (AUC) value of 0.730. The same results were obtained when meta-analyses were performed separately, in the seven studies reporting (8175 patients with 358 events; mortality rate, 4.4%), the ROC curve provided an average AUC value of 0.724. The five studies not reporting reliable uncertainty estimation (18, 446 patients with 892 events; mortality rate, 4.8%) had an average AUC of 0.732. Studies documented a constant trend to over predict mortality by EuroSCORE, both in the additive and especially in the logistic form. In conclusion, The EuroSCORE has low discrimination ability for valve surgery, and it sensibly over predicts risk. Alternative risk scoring algorithms, EuroSCORE II should be seriously considered (Alessandro, et al., 2010) . National Heart Foundation Hospital and Research Institute (NHFH&RI), Dhaka, is a high volume cardiac center in Bangladesh. At NHFH&RI, previously a study was done to assess the performance of former EuroSCORE model among coronary artery bypass grafting (CABG) patients (Rahman MZ, et al.2012) although performance of EuroSCORE II has never been tested in valve surgery patients. The aim of this work in this center is to evaluate the current clinical profile of patients submitted to mitral and aortic valve surgery and to check expected risk of death in this group of patients by applying EuroSCORE II and compare its predictive performance with additive EuroSCORE (AES) and logistic EuroSCORE (LES) in terms of calibration and discrimination, thus to see whether EuroSCORE II could validate risks on our patient at NHFH&RI.
Rationale: The European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) is an updated version of the original EuroSCORE and used for prediction of early mortality in cardiac surgery patients in Europe. This risk scoring system has been found highly successful on CABG patients and previously two study were conducted at NHFH&RI. But its validity was never been tested on mitral and aortic valve surgery of our population.
At present, NHFH&RI a high volume center in Bangladesh operating various valve surgery which is about more than 30% of total surgery. The EuroSCORE II predicted value can be used in mitral and aortic valvular surgery for preoperative decision making & risk assessment, counselling of patient, fitness of patients ,management planning, postoperative outcome & follow-up and make a comparison between institutions and surgeons.
So, significant differences in the demography ,risk profiles, surgical strategy in different countries of the world made individual population study necessary to confirm the predictive value of this pan-European method in that population.
The purpose of this study is to see whether EuroSCORE II can predict early mortality after elective mitral and aortic valve surgery & optimize its usefulness in valve surgery in NHFH&RI and compare its predictive performance with additive and logistic EuroSCORE. 
Follow up of patient
Patients were discharged at the 7 th postoperative day routinely unless any of them were complicated by any factor. 1) Those who were successfully discharged was contacted via mobile phone at the 31 st postoperative day whether any mortality event occur and record accordingly.
2) Those who were complicated by any factor and had postoperative hospital stay prolong were followed till their discharge or any mortality event and record accordingly. with Hosmer-lemeshow chi square test and discriminatory capacity (statistical capacity) with ROC curve. And association between observed and predicted mortality were assessed by comparing the observed and predicted mortality figure with 95% confidence interval using Pearson chi square test, p value less than <0.05 considered significant.
Surgical

Results:
This was a prospective cohort study conducted in the department of cardiac surgery, from July 2016 to June 2018 among the patients admitted for valve surgery. After fulfilling the inclusion and exclusion criteria a total of 356 patients were enrolled in this study.
Distribution of the patients by age shows majority of patients were within 4 th decade and was mean age 43.29 ± 12.35. In this study 49.4% patients were male and 50.6% were female. Table II shows shows association between weight of intervention and early mortality was statistically not significant. Table III shows shows single valve surgery mortality 2.3 % ( 7 out of 296) and double valve surgery mortality 5.7 % (3 out of 50), association between single and double valve operation and early mortality was statistically not significant. 
Discriminatory capacity of the EuroSCORE model
It was analyzed by calculating the area under the ROC curve .The models ability to discriminate was assessed in terms of its capacity to distinguish between patients who died during hospitalization from those who did not. Typical C values for cardiac surgery models range from 0.72 to 0.76 that means prediction of individual outcome is correct 72% to 46% of the time. A value of 0.5 indicates no discrimination and a value of 1.0 indicates perfect predictor. Areas of greater than 0.7 are generally thought to be useful .The discriminatory power of the model is Excellent if ROC exceeds 0.80, Very good if it exceeds 0.75 and good if it exceeds 0.70.
In this study, the model's discriminatory power was found good and useful, as indicated by an area under ROC curve of 0.779 in EuroSCORE II model, 0.675 in additive method and 0.696 in logistic method that means EuroSCORE II can predict the outcome with 77% accuracy, additive method does with 67% accuracy and logistic method with 69% accuracy.
The 
Discussion:
The current clinical profile of patients submitted to heart surgery puts into question the incidence of operative or hospital deaths as reliable indicators and not sufficient to evaluate the quality of services provided by the cardiac hospital. Without individual risk adjustment, taking into considerations associated risk factors, the conclusions might be incorrect. Prognostic models which take into account patients specific characteristics and which provides risk adjusted outcomes for intervention are required and more useful to allow meaningful comparison of outcomes to be performed between institutions and surgeons.
The choices available to a surgical unit are to create a new model, recalibrate an existing model or to use a ready-made model. The former two options are impractical to most cardiac surgical units as they require comprehensive database management and accumulation of large patient number to allow creation or recalibration of a model .The use of a ready-made widely used model has the additional advantage of allowing meaningful comparison to be made regionally and internationally.
Different systems of risk stratification have been utilized over the last two decades in different countries with the objective of predicting mortality in cardiac surgery. Additionally the application of a scoring system provides information to patients and their families in respect to the risk that individual patients will be submitted.
In the recent years the EuroSCORE has become one of the most widely used prognostic scoring system. Among the different studies to stratify the risk, the Euro score In our patient majority were female 50.6% ( 180 out of 356) and male were 49.4% (176 out of 356) .According to Nashef, et al., females have a higher mortality than males.
The mean serum creatinine of our study was 1.10 ± 0.21 t test was done to measure the level of significance P = 0.927 and it is considered not significant. Renal function was assessed by the estimated creatinine clearance using the Cockroft-Gault formula, and it is a better predictor than serum creatinine (Nashef,et al.,2012) . In this study early mortality is seen in moderately impaired renal function. By this present study, we validated the EuroSCORE II model for use in this centre and that it has been proven to be a reliable instrument for risk stratification. This signifies that the model's predictions of the probability of dying are valid and appropriately risk-adjusted for patients undergoing valve surgery in National Heart Foundation Hospital & Research Institute.
Limitation: This analysis was done in a single centre of Bangladesh, and the sample represents only a fraction of patients undergoing valve surgery in Bangladesh. The focus of this study was adult patients undergoing valve surgery, the identified independent risk factors may not be applicable to other surgeries as aortic surgery, congenital heart surgery or heart transplantation.
Conclusion:
The results of this study allow us to conclude that despite substantial demographic and epidemiological differences between Bangladesh and European population EuroSCORE II was validated and performed well on NHFH&RI patients and could be recommended as a simple risk stratification system to estimate the probability of early mortality in patients scheduled for valve surgery in Bangladesh.
This study demonstrates that the EuroSCORE II is more accurate in predicting operative mortality than the additive EuroSCORE (AES) and logistic EuroSCORE (LES) in patients undergoing valve surgery patients. The model validated in the present study could be useful in providing systematic information on the outcome of valve surgeries in other centers of Bangladesh.
